Canton Hathaway’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$310K Buy
8,600
+2,730
+47% +$98.4K 0.06% 118
2025
Q1
$231K Buy
+5,870
New +$231K 0.05% 130